VAERS reports by lot

GSK Varicella/Shingles lot 54A2T: VAERS reports

21 VAERS reports list lot 54A2T as a GSK Varicella/Shingles vaccine, received between 2019-10-19 and 2021-01-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2332%
General / Systemic (non-local)1825%
Dermatological (non-injection-site)1014%
Musculoskeletal68%
Neurological34%
Allergic / Anaphylactic34%
Gastrointestinal34%
Cardiac / Cardiovascular23%
Autoimmune / Immune-mediated11%
Respiratory11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas4
California4
Oregon2
Alabama2
Oklahoma1
Arizona1
Iowa1
Wisconsin1
Idaho1
Georgia1
Ohio1
Kansas1

Reports by month received

2019-102
2019-115
2019-123
2020-015
2020-021
2020-061
2020-071
2020-082
2021-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.